(Updated - July 28, 2026 6:49 AM EDT)

Guggenheim analyst Brad Canino raised the price target on Kymera Therapeutics ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE